AffinityImmuno Eyes Licensing Partner

Charlottetown-based AffinityImmuno is looking for a larger partner to licence out its product that tests whether a person has antibodies that can ward off COVID-19.
The four-year-old company specializes in antibodies, which are proteins used by the human body’s immune system to search out “foreign invaders” like viruses, bacteria, fungi or parasites. Once the antibodies detect these invaders,